Open Field 33 · Information services
Careful guides, comparison frameworks, research summaries, and plain-language reference material for people evaluating ibogaine addiction clinics.
Safety before promises
A careful starting point
Open Field 33 is an independent resource for evaluating ibogaine treatment options carefully. Our work is built for people affected by substance use, their families, and professionals who need a calmer way to weigh claims, uncertainty, safety practices, evidence, and legal context.
The broader ibogaine clinic comparison framework begins with a simple premise: information can clarify what to ask, but it cannot turn a marketing claim into proof. The purpose and approach behind Open Field 33 explain how this resource keeps that distinction visible.
The working set
Our guides gather the questions people encounter when comparing programs: what is being described, what is not stated, and what should be checked independently. For people sorting through mood-related claims, the material on ibogaine and depression can help distinguish a topic for inquiry from a promise of treatment.
Comparison tools make room for practical criteria such as screening, monitoring, emergency planning, follow-up, costs, and transparency. When opioid use is part of the question, our ibogaine opioid treatment overview supports a more deliberate review of the language a program uses and the questions it leaves unanswered.
Terms can change across websites, countries, and conversations. The ibogaine terminology reference helps readers recognize alternate names and wording before assuming that two descriptions mean the same thing. This is especially useful where unfamiliar language can make a program sound more settled than it is.
We summarize research context without presenting it as individualized medical guidance. Ibogaine is a psychoactive alkaloid derived from plants in the Tabernanthe iboga plant tradition, and its use raises safety questions that need more than shorthand. Our research notes keep the difference between preliminary interest, clinical evidence, and promotional language in view.
The comparison bench
Some comparisons need to account for location as well as language. Readers considering care across the border can examine how a Tijuana ibogaine clinic describes its process, then contrast that account with broader questions about an ibogaine treatment facility in Mexico. The purpose is not to rank providers or direct anyone to a clinic; it is to make criteria visible.
Provenance, not promotion
Claims about ibogaine are often repeated without enough context about the setting, the people involved, or the limits of a finding. The U.S. Food and Drug Administration explains that its role includes reviewing drug safety and effectiveness before products are marketed in the United States; its drug development and approval overview is useful context for understanding why interest in a substance is not the same as established approval.
Common questions
No. Open Field 33 provides independent information for comparison and discussion. It is not a clinic, medical provider, or licensed treatment center, and its material does not replace professional evaluation.
No. A guide can make questions more specific and help a reader notice missing information. It cannot determine suitability, safety, legality, or likely outcomes for any individual.
Because a comparison without risk context can mislead. The National Institute on Drug Abuse treatment resources describe addiction treatment as a broad area of care, reinforcing the value of careful, evidence-aware questions rather than one-size-fits-all claims.
Use the framework carefully
Use the clinic comparison material as a way to slow down, document what is stated, and identify what still needs independent verification.